Sanchez-Cuadrado Isabel, Calvino Miryam, Morales-Puebla Jose Manuel, Gavilán Javier, Mato Teresa, Peñarrocha Julio, Prim Maria Pilar, Lassaletta Luis
Department of Otolaryngology, La Paz University Hospital, Madrid, Spain.
IdiPAZ Research Institute, Madrid, Spain.
Front Neurol. 2021 Jun 17;12:670137. doi: 10.3389/fneur.2021.670137. eCollection 2021.
Menière's disease (MD) is a disorder characterized by auditory and vestibular dysfunction that significantly deteriorates patients' quality of life (QoL). In addition to the management of vestibular symptoms, some patients with bilateral hearing loss meet criteria for cochlear implantation (CI). (1) To assess hearing results and QoL outcomes following CI in patients with MD. (2) To compare these results to a matched control group of patients who had undergone CI. (3) To analyse differences in MD patients who have undergone simultaneous or sequential labyrinthectomy or previous neurectomy. A retrospective analysis of a study group of 18 implanted patients with MD and a matched control group of 18 implanted patients without MD, who had CI at a tertiary referral center. Hearing and speech understanding were assessed via pure-tone audiometry (PTA) and disyllabic perception tests in quiet. QoL was assessed the Nijmegen Cochlear Implant Questionnaire (NCIQ), the Glasgow Benefit Inventory (GBI), the Speech, Spatial and Qualities of Hearing Scale (SSQ), and the Hearing Implant Sound Quality Index (HISQUI). The impact of MD ablative surgeries was analyzed in the study group (MD group). Mean pre-operative PTA thresholds were significantly lower in the MD group (103 vs. 121 dB). A significant improvement in hearing outcomes was observed following CI in both groups ( < 0.001), with a maximum Speech Discrimination Score of 64 and 65% disyllables at 65 dB for the MD and control group, respectively. Subjective outcomes, as measured by the NCIQ, GBI, SSQ, and HISQUI did not significantly differ between groups. In the MD group, despite achieving similar hearing results, QoL outcomes were worse in patients who underwent simultaneous CI and labyrinthectomy compared to the rest of the MD group. Post-operative NCIQ results were significantly better in patients who had undergone a previous retrosigmoid neurectomy when compared to those who had undergone only CI surgery in the subdomains "basic sound perception" ( = 0.038), "speech" ( = 0.005), "activity" ( = 0.038), and "social interactions" ( = 0.038). Patients with MD and severe hearing loss obtain hearing results and QoL benefits similar to other CI candidates. Delayed CI after labyrinthectomy or vestibular neurectomy can be performed with similar or better results, respectively, to those of other cochlear implanted patients. Patients who undergo simultaneous CI and labyrinthectomy may achieve similar hearing results but careful pre-operative counseling is needed.
梅尼埃病(MD)是一种以听觉和前庭功能障碍为特征的疾病,会显著降低患者的生活质量(QoL)。除了前庭症状的管理外,一些双侧听力损失的患者符合人工耳蜗植入(CI)标准。(1)评估MD患者CI后的听力结果和生活质量结局。(2)将这些结果与接受CI的匹配对照组患者进行比较。(3)分析同时或序贯进行迷路切除术或先前接受神经切除术的MD患者之间的差异。对一家三级转诊中心的18例植入人工耳蜗的MD研究组患者和18例未患MD的植入人工耳蜗匹配对照组患者进行回顾性分析。通过纯音听力测定(PTA)和安静环境下的双音节感知测试评估听力和言语理解能力。使用奈梅亨人工耳蜗问卷(NCIQ)、格拉斯哥获益量表(GBI)、言语、空间和听力质量量表(SSQ)以及人工耳蜗声音质量指数(HISQUI)评估生活质量。在研究组(MD组)中分析MD消融手术的影响。MD组术前平均PTA阈值显著更低(103 vs. 121 dB)。两组CI后听力结果均有显著改善(<0.001),MD组和对照组在65 dB时的最大言语辨别得分分别为64%和65%的双音节。通过NCIQ、GBI、SSQ和HISQUI测量的主观结果在两组之间无显著差异。在MD组中,尽管听力结果相似,但与MD组其他患者相比,同时接受CI和迷路切除术的患者生活质量结局更差。与仅接受CI手术的患者相比,先前接受乙状窦后神经切除术的患者在“基本声音感知”(=0.038)、“言语”(=0.005)、“活动”(=0.038)和“社交互动”(=0.038)子领域的术后NCIQ结果显著更好。患有MD和严重听力损失的患者获得的听力结果和生活质量益处与其他CI候选者相似。迷路切除术或前庭神经切除术后延迟进行CI,分别可获得与其他人工耳蜗植入患者相似或更好的结果。同时接受CI和迷路切除术的患者可能获得相似的听力结果,但术前需要仔细咨询。